نتائج البحث 1051-1060 من 19550 لعملية البحث عن Two-phase
... 2 focuses on primary or secondary myelofibrosis (MF) displaying mutated ... (2-4) advanced, unresectable breast cancer (up to 6 donors per phenotype ...
... phase II dose (RP2D of APG2575 in combination with Pomalidomide/dexamethasone (Pd) in patients with relapsed/refractory (R/R) multiple myeloma (MM), or ...
... Stage 4 colorectal cancer, Pathologic fracture, Spondylotic myelopathy, Spondylolysis, Spinal metastasis, Spinal fracture, Stage ... توجّه للصفحة 22 · توجّه للصفحة ...
A Study to Test the Effectiveness of Two Immunotherapy ... This phase II trials studies how well ... two lines of therapy as measured by objective ...
Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...
Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA ... This is a Phase I/II study designed to evaluate ... two cycles of mosunetuzumab. An additional arm ...
This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients with HER2 expressing ductal ...
Phase I/II Study of [225Ac]Ac-PSMA-R2 in PSMA ... two cycles of mosunetuzumab. An additional arm ... MC1733, Phase I Trial of Intratumoral ...
... (2) improves stroke outcomes at 3 months in patients who ... A Phase 3 Efficacy and Safety Study of Pitolisant in Patients with Prader-Willi Syndrome.
This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.